Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

From left to right: Dr. Louis DeGennaro, LLS President & CEO; Dr. Stephen Ansell, LLS Excellence in Scientific Service recipient; Dr. Gwen Nichols, LLS Chief Medical Officer; Dr. Lee Greenberger, LLS Chief Scientific Officer

The Leukemia & Lymphoma Society Honors Six Outstanding Blood Cancer Scientists with 2022 Achievement Awards

December 23, 2022

FDA Approved Misc

FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults

December 2, 2022

Researcher

The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients

November 28, 2022

The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator

November 16, 2022

FDA-Approval-Misc

LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma

November 11, 2022

FDA Approval Misc

Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases

November 4, 2022

Shred for Red

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

October 31, 2022

Breaking News Myeloma

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma

October 27, 2022

Fast Company

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

October 24, 2022

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.